Pulmonx (LUNG) Free Cash Flow Growth (1y) (2020 - 2025)
Powered by 
Analysis
Pulmonx (LUNG) Free Cash Flow Growth (1y) (2020 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.08 Bn | 174.48 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 127.86 Bn | 122.64 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.15 Bn | 108.33 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 103.82 Bn | 100.34 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.76 Bn | 45.51 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 32.95 Bn | 31.49 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.22 Bn | 30.27 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | -14.34% |
| 10 | Pulmonx | 76.96 Mn | 7.21 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -8.23% |
| Jun 30, 2025 | 37.82% |
| Mar 31, 2025 | -10.94% |
| Dec 31, 2024 | 20.55% |
| Sep 30, 2024 | 13.59% |
| Jun 30, 2024 | 20.36% |
| Mar 31, 2024 | 6.57% |
| Dec 31, 2023 | 13.69% |
| Sep 30, 2023 | 19.65% |
| Jun 30, 2023 | 20.27% |
| Mar 31, 2023 | 15.89% |
| Dec 31, 2022 | 15.80% |
| Sep 30, 2022 | -10.68% |
| Jun 30, 2022 | 26.11% |
| Mar 31, 2022 | -56.81% |
| Dec 31, 2021 | -50.81% |
| Sep 30, 2021 | -56.71% |
| Jun 30, 2021 | -72.67% |
| Mar 31, 2021 | -3.35% |
| Dec 31, 2020 | -111.13% |